Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Corvex (MOVE) Research & Development (2020 - 2025)

Corvex filings provide 2 years of Research & Development readings, the most recent being $790000.0 for Q4 2025.

  • On a quarterly basis, Research & Development fell 60.44% to $790000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $5.7 million, a 48.73% decrease, with the full-year FY2025 number at $5.7 million, down 48.73% from a year prior.
  • Research & Development hit $790000.0 in Q4 2025 for Corvex, down from $1.2 million in the prior quarter.
  • In the past five years, Research & Development ranged from a high of $3.4 million in Q3 2024 to a low of $790000.0 in Q4 2025.